Joshua L Manghelli1, Daniel I Carter1, Ali J Khiabani1, Jason M Gauthier1, Marc R Moon1, Nabil A Munfakh2, Ralph J Damiano1, Joel S Corvera3, Spencer J Melby4. 1. Division of Cardiothoracic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, Mo. 2. Division of Cardiothoracic Surgery, Christian Northeast Hospital, Washington University School of Medicine, St Louis, Mo. 3. Division of Cardiothoracic Surgery, Indiana University School of Medicine, Methodist Hospital, Indianapolis, Ind. 4. Division of Cardiothoracic Surgery, Barnes-Jewish Hospital, Washington University School of Medicine, St Louis, Mo. Electronic address: smelby@wustl.edu.
Abstract
OBJECTIVE: Valve selection in dialysis-dependent patients can be difficult because long-term survival is diminished and bleeding risks during anticoagulation treatment are greater in patients with renal failure. In this study we analyzed long-term outcomes of dialysis-dependent patients who underwent valve replacement to help guide optimal prosthetic valve type selection. METHODS: Dialysis-dependent patients who underwent aortic and/or mitral valve replacement at 3 institutions over 20 years were examined. The primary outcome was long-term survival. A Cox regression model was used to estimate survival according to 5 ages, presence of diabetes, and/or heart failure symptoms. RESULTS: Four hundred twenty-three available patients were analyzed; 341 patients had biological and 82 had mechanical valves. Overall complication and 30-day mortality rates were similar between the groups. Thirty-day readmission rates for biological and mechanical groups were 15% (50/341) and 28% (23/82; P = .005). Five-year survival was 23% and 33% for the biological and mechanical groups, respectively. After adjusting for age, New York Heart Association (NYHA) class, and diabetes using a multivariable Cox regression model, survival was similar between groups (hazard ratio, 0.93; 95% confidence interval, 0.66-1.29; P = .8). A Cox regression model on the basis of age, diabetes, and heart failure, estimated that patients only 30 or 40 years old, with NYHA class I-II failure without diabetes had a >50% estimated 5-year survival (P < .001). CONCLUSIONS: Dialysis-dependent patients who underwent valve replacement surgery had poor long-term survival. Young patients without diabetes or NYHA III or IV symptoms might survive long enough to justify placement of a mechanical valve; however, a biological valve is suitable for most patients.
OBJECTIVE: Valve selection in dialysis-dependent patients can be difficult because long-term survival is diminished and bleeding risks during anticoagulation treatment are greater in patients with renal failure. In this study we analyzed long-term outcomes of dialysis-dependent patients who underwent valve replacement to help guide optimal prosthetic valve type selection. METHODS: Dialysis-dependent patients who underwent aortic and/or mitral valve replacement at 3 institutions over 20 years were examined. The primary outcome was long-term survival. A Cox regression model was used to estimate survival according to 5 ages, presence of diabetes, and/or heart failure symptoms. RESULTS: Four hundred twenty-three available patients were analyzed; 341 patients had biological and 82 had mechanical valves. Overall complication and 30-day mortality rates were similar between the groups. Thirty-day readmission rates for biological and mechanical groups were 15% (50/341) and 28% (23/82; P = .005). Five-year survival was 23% and 33% for the biological and mechanical groups, respectively. After adjusting for age, New York Heart Association (NYHA) class, and diabetes using a multivariable Cox regression model, survival was similar between groups (hazard ratio, 0.93; 95% confidence interval, 0.66-1.29; P = .8). A Cox regression model on the basis of age, diabetes, and heart failure, estimated that patients only 30 or 40 years old, with NYHA class I-II failure without diabetes had a >50% estimated 5-year survival (P < .001). CONCLUSIONS: Dialysis-dependent patients who underwent valve replacement surgery had poor long-term survival. Young patients without diabetes or NYHA III or IV symptoms might survive long enough to justify placement of a mechanical valve; however, a biological valve is suitable for most patients.
Authors: Vincent Chan; W R Eric Jamieson; Arlen G Fleisher; David Denmark; Florence Chan; Eva Germann Journal: Ann Thorac Surg Date: 2006-03 Impact factor: 4.330
Authors: Farzan Filsoufi; Joanna Chikwe; Javier G Castillo; Parwis B Rahmanian; Joseph Vassalotti; David H Adams Journal: Nephrol Dial Transplant Date: 2008-07-07 Impact factor: 5.992
Authors: William T Brinkman; Willis H Williams; Robert A Guyton; Ellis L Jones; Joseph M Craver Journal: Ann Thorac Surg Date: 2002-07 Impact factor: 4.330
Authors: Kevin S Kim; Emilie P Belley-Côté; Saurabh Gupta; Arjun Pandey; Ali Alsagheir; Ahmad Makhdoum; Graham McClure; Brooke Newsome; Sophie W Gao; Matthias Bossard; Tetsuya Isayama; Yasuhisa Ikuta; Michael Walsh; Amit X Garg; Gordon H Guyatt; Richard P Whitlock Journal: Can J Surg Date: 2022-07-12 Impact factor: 2.840